Of note, knockdown NFE2L3 showed a significant increase in the protein levels of NFE2L1 in colon cancer cells, implying a complex regulatory relationship between NFE2L3 and proteasome activity (Waku et al., 2020a). This evidence concerns the gene NFE2L3 and colonic neoplasm.